Neoadjuvant chemotherapy in cervix cancer
Despite the decrease in the incidence of cervix cancer over the last decade, 13 500 new cases and 4400 deaths were expected in the United States in 1992 . Accessibility of the cervix for cytologic evaluation via the Pap smear, visual inspection by colposcopy, and histologic evaluation by biopsy have made cervical cacer a preventable and potentially curable disease. Identification and successful treatment of precursor lesions (cervical intraepithelial neoplasia) have accounted for the decreasing incidence. Cervix cancer is prevalent among women of low socioeconomic groups, high sexual promiscuity, and multiparity. It has been found to be associated with human papilloma virus infection; however, the precise role played by viral infection in cervix cancer remains to be defined. However, there is evidence accumulating linking HPV type 16, 18, 31, and 35 infections with lower-genital-tract cancers. This has led investigators to view cervical cancer as a sexually transmitted disease.
KeywordsRadium Oncol Doxorubicin Methotrexate Gallion
Unable to display preview. Download preview PDF.
- 1.Boring CC, Squires TS, Tong T (1992). Cancer Stat 42:1.Google Scholar
- 4.Martinbeau P, Kjorstad K (1982). Iversen Stage IB carcinoma of the cervix. The Norwegian Radium Hospital. II. Results when pelvic nodes are involved. Obstet Gynecol 60:215.Google Scholar
- 6.Pilleron JP, Durand JC, Hamelin JP (1974). Prognostic value of node metastasis in cancer of the uterine cervix. Am J Obset Gynecol 119:458–462.Google Scholar
- 7.Inover T, Okumura M (1984). Prognostic significance of parametrial extension in patients with cervical carcinoma Stage IB, IIA and IIIB. Cancer 51:1714.Google Scholar
- 13.Kinney WK, Alvarez RD, Reid GC, Schray MF, Soong S, Morley GW, Podratz KC, Shingleton HM (1989). Value of adjuvant whole-pelvis irradiation after Wertheim hysterec-tomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: A matched-control study. Gynecol Oncol 34:258–262.PubMedCrossRefGoogle Scholar
- 16.Lipsztein R, Kredenster D, Dottino PR, Goodman HM, Dalton JF, Bloomer WD, Cohen CJ (1988). Combined chemotherapy and radiation therapy for advanced carcinoma of the cervix. Am J Clin Oncol 29(3):348–355.Google Scholar
- 18.Fletcher GH (1980). Textbook of Radiotherapy, 3rd ed. Philadelphia: Lea and Febiger, pp. 720–773.Google Scholar
- 20.Bonomi P, Blessing J, Stehman FB, et al. (1985). Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix. A Gynecologic Oncology Group study. J Clinical Oncol 3:1079–1085.Google Scholar
- 24.Hreschchyshyn M (1963). Vincristine treatment of patients with carcinoma of the uterine cervix. Proc AACR 4:29.Google Scholar
- 35.Deppe G, Malviya VK, Han I, Christensen CW, Malone JM Jr, Kim Y, Ahmad K (1991). A preliminary report of combination chemotherapy with cisplatin and mitomycin-C followed by radical hysterectomy or radiation therapy in patients with locally advanced cervical cancer. Gynecol Oncol 42:178–181.PubMedCrossRefGoogle Scholar
- 50.Kirsen F, Atkinson KH, Coppleson JVM, Elliott PM, Green D, Houghton R, Murray JC, Russell P, Solomon HJ, Friedlander M, Swanson CE, Tattersall MGN (1987). Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer. Br J Obstet Gynecol 94:583–588.CrossRefGoogle Scholar